Allergy Therapeutics PLC Director Share Dealings (0973U)
July 27 2015 - 2:00AM
UK Regulatory
TIDMAGY
RNS Number : 0973U
Allergy Therapeutics PLC
27 July 2015
27 July 2015
Allergy Therapeutics plc
Director Share Dealings
On 24 July 2015, the Board of Allergy Therapeutics plc ("Allergy
Therapeutics" or "the Company") was informed that on 24 July 2015,
Manuel Llobet, Chief Executive Officer, purchased 50,000 ordinary
shares of 0.10p ("Ordinary Shares") at a price of 24.45p per share.
Mr Llobet's beneficial holding now stands at 3,175,000 Ordinary
Shares, which represents 0.58% of the issued share capital of the
Company to which voting rights are attached.
- Ends -
For further information:
+44 (0) 1903 845
Allergy Therapeutics 820
Ian Postlethwaite, Finance Director
+44 (0) 20 7886
Panmure Gordon 2500
Freddy Crossley / Peter Steel / Duncan Monteith,
Corporate Finance
Tom Salvesen, Corporate Broking
+44 (0) 20 3727
FTI Consulting 1000
Simon Conway / Victoria Foster Mitchell
Note to editors:
About Allergy Therapeutics
Allergy Therapeutics is a specialty pharmaceutical company
focused on allergy vaccination. It has a growing business achieving
revenue in the last financial year of GBP42 million mainly in
Europe through its own sales and marketing infrastructure and
further afield through distributors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSSEFEEMFISESW
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Sep 2023 to Sep 2024